Great conversation and your future is bright 😎

Wonderful UTSW Simmons Cancer Center ASCO #ASCO24 reception on the rooftop! Our Dallas crew having a superb time thinking #cancerresearch & enjoying Chicago weather! Carlos L. Arteaga, M.D. Suzanne Conzen Sangeetha Reddy Suzanne Cole, MD Charles Jiang MD, MPH Wadih Issa, MD UTSW Hematology & Oncology UT Southwestern Medical Center

Extremely proud of this ⭐️ student Dr Vanessa Moore presenting her work on health insurance plans offered to employees at NCI-Designated cancer centers at #ASCO24!! Ryan Nipp, MD, MPH University of Oklahoma Research Charles Jiang MD, MPH Jiazhang Xing

Dr Ryan Nipp, MD, MPH with an excellent summary #ASCO24 on THREE randomized studies focused on improving the LIVED EXPERIENCE of cancer treatment and survivorship. ✅ We ARE moving the needle in advancing patient-centered care.

Exceptional Hem/onc aspirant Zhiting Tang has TWO first author posters ASCO 2024! Hem/onc PDs, please watch out for her applicantions! IMG Oncologists Hem-Onc Fellows Network H.O.M.E Nazli Dizman Ziad Bakouny, MD, MSc Toni Choueiri, MD

Christina Ruhlmann #mascc24 late chronic tox with immunotherapies #supponc

Nice talk from Prof Professor Ray Chan on resource stratified #supponc #survonc guidelines #MASCC24

Just finished co-chairing excellent session on disparities in cancer supportive care with Charles Jiang MD, MPH at #MASCC24 . Excellent work being done both locally and through MASCC to help narrow the gaps in this area. MASCC Professor Ray Chan, Viktor Clark, Marg Fitch.

Great experience learning and witnessing so many great work in this space !

Our research on US cancer survivors: Over 50% facing financial hardship also experience food, housing, or transportation insecurity. Highlights crucial need for social determinants of health screening and support. UTSW Simmons Cancer Center Tian Zhang, MD, MHS Xuesong Han

Disparity Committee was very productive at #MASCC24 - we discussed DEI issues, resource stratified guidelines, inc LMIC participation within MASCC, LGBTQ+ health. Strong leadership by Enrique Soto Don S. Dizon MD (he/him) 🇬🇺 and great members!

Embedding Patient and Health Care Professional Voices in Clinical Trials. jamanetwork.com/journals/jama/… JAMA JAMA Oncology JAMA Internal Medicine #ClinicalTrials #CancerResearch #Healthcare

Our study in JCO Global Oncology explores financial toxicity & unmet social needs in cancer care across HIC & LMIC Alex Chan, PharmD, MPH Charles Jiang MD, MPH Ana I. Velázquez Mañana, MD, MSc, FASCO Enrique Soto & cols MASCC survey reveals disparities in cost burdens and support availability ascopubs.org/doi/pdfdirect/…

We (the AC2 Partners) are hosting our FIRST EVER bilingual webinars on cancer survivorship, specifically #FCR today! #Survonc Wendy Lam HKU Medicine Flinders Caring Futures Institute Flinders University Australian Cancer Survivorship Centre Prof Michael Jefford Bogda Koczwara 🌻🌻🌻 #supponc MASCC Department of Foreign Affairs and Trade 🇦🇺 ac2project.org

⏳ Time's running out! ⏳ Secure your spot at the ASCO #ASCOQLTY24 before reduced fees end on 08/21. Don't miss this chance to connect with leaders in oncology care—register today! conferences.asco.org/quality/regist…

Thank you Tian and Petros for highlighting!

Grateful for all tremendous support I get at UTSW Simmons Cancer Center ! Big thanks to Tian Zhang, MD, MHS QianJanieQin and everyone's support!

In case you are going to #wclc24, check out this great career development event developed by Lei Deng, MD (He/Him) !

Completely agree. Our under-reviewed study found that 90% of Medicare Advantage PD and 70% of PDP patients require prior authorization just to get standard generic zofran tablets (not even ODT).... It only costs insurance $20ish for 1 month supply...

Our MASCC Health Disparities Working Group newest publication is now available on CancerMedicine highlighting global disparities in #cancer supportive care Led by Alex Chan, PharmD, MPH Enrique Soto & outstanding team #SuppOnc #PallOnc #SurvOnc Read ➡️